The development of technology of Fludeoxyglucose (18F) for injection, laboratory analysis methods
Journal Title: Фармацевтичний журнал - Year 2017, Vol 1, Issue 1
Abstract
18F-Fluorodeoxyglucose has optimal characteristics for use in nuclear medicine and is a priority among radiopharmaceuticals for the diagnosis of cancer by positron emission tomography (PET). 18F-Fluorodeoxyglucose has the longest half-life with the lowest energy of radiation, it allows to obtain PET images of high contrast at low dose loading on the patient. Low energy positron radiation provides high spatial resolution of PET images. However, the half-life of 18F-Fluorodeoxyglucose is large enough to allow the transportation of radiopharmaceuticals from the centralized production site to diagnostic centers with PET scanners (the so-called PET satellite concept), and to extend the time limits of PET research and synthesis of radiopharmaceuticals [1]. The study is the development of technology and quality control methods to ensure quality at all stages of the production of radiopharmaceuticals 18F-Fluorodeoxyglucose, injection. There was justified 18F-Fluorodeoxyglucose production technology and quality control at all stages of production, based on complex research in the department producing radiopharmaceuticals Ukrainian Center of radiosurgery consisting Clinical Hospital «Feofaniya». Object of study – 18F-Fluorodeoxyglucose, injection, injection is used in nuclear medicine for PET diagnosis of cancer. We used the biopharmaceutical and pharmaceutical methods. For the first time based pharmaceutical research was the rational technology of diagnostic radiopharmaceuticals 18F-Fluorodeoxyglucose, injection for use in PET diagnosis of cancer patients. Methods of controlling drug 18F-Fluorodeoxyglucose, injection according monographs of the State Pharmacopoeia of Ukraine. On the basis of the analysis developed by established methods of control performance specifications and shelf life of radiopharmaceuticals 18F-Fluorodeoxyglucose, injection.
Authors and Affiliations
V. V. Kachaniuk, S. Y. Sarychev
Keywords
Related Articles
- EP ID EP554018
- DOI 10.32352/0367-3057.1.17.07
- Views 72
- Downloads 0
Approaches to optimize pharmaceutical and medical care of patients with psoriasis
Features of psoriasis as chronic inflammatory disease, frequent recurrence, the short periods of remission, psycho-emotional disadaptation, decline in quality of patient life and unsatisfied need for safe and effective t...
State principles of the medicines circulation regulation around the world and in Ukraine in the pharmacotherapy of orphan diseases among disabled children based on pharmaceutical law
Most rare diseases are serious chronic health problems, many of which accompanied by alarming symptoms that affect the quality and length of life. According to the WHO experts, the number of disabled children in Ukraine...
Determination of shelf life, storage conditions and packaging materials for suppositories Altabor
Stable is a fixture in the quality of pharmaceutical products. At the organization of studies on the stability is important to understand that drugs – is mostly multi-active system, which occur simultaneously different p...
In silico screening of drug-like molecules for the treatment of cardiovascular diseases on the basis of five-membered privileged heterocycles
Among various heterocyclic systems, the derivatives of five-membered heterocycles are of special interest. Most of the above mentioned heterocycles are treatred as so-called privileged structures in modern medicinal chem...
Synthesis and study of the properties of derivatives 4-phenyl-5-(1H-pyrrol-2-yl)-4H-1,2,4-triazole-3-thiols
The successful use of drugs, derivatives of 1,2,4-triazole, creates the conditionsfor the production and investigation of properties of new derivatives of this heterocyclic system. The aim of this work was synthesis and...